EqualSpheres Narrow-size Embolic Microspheres

Launched in 2021, EqualSpheres® Narrow-size Embolic Microspheres incorporates patented technology and has obtained approvals from both the China NMPA and the USA FDA (510k). It is intended to be used for the embolization of arteriovenous malformations (AVMs) and hyper vascular tumors, including uterine fibroids. So far, it’s successfully deployed in thousands of hospitals and primarily employed for the embolization treatment of various solid malignant tumors, including primary liver cancer, metastatic liver cancer, lung cancer, kidney cancer, cervical cancer, prostate cancer, and soft tissue sarcoma.